For more information or to register for this event, visit Beyond 3+3: Rethinking Early-Phase Oncology Study Design.
GOLETA, Calif.--(BUSINESS WIRE)--Serimmune, a leader in understanding the antibody repertoire's role in human disease, announced today the publication of a study in Nature in which their proprietary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback